USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AMULET PHARMACEUTICALS, INC.
Address:
AMULET PHARMACEUTICALS, INC.
9430 Key West Avenue
Rockville, MD 20850
Phone:
N/A
URL:
N/A
EIN:
522334293
DUNS:
148048460
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $783,970.00 6
SBIR Phase II $472,075.00 1

Award List:

THE ELFL PROTEIN AS A NOVEL ANTIFUNGAL TARGET

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,918.00
Agency:
HHS
Principal Investigator:
Sheldon E. Broedel
Abstract:
Not Available The Institute for Laser Technology (ILT), as the prime contractor, the University of Southern California Center for Laser Studies (USC-CLS) and Raytheon Systems Company, as subcontractors, propose to develop a compact, robust, OPO tuner for solid state lasers that can be integrated… More

HISTIDINE KINASE ASSAY FOR DISCOVERY OF NEW ANTIFUNGALS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,558.00
Agency:
HHS
Principal Investigator:
Sheldon E. Broedel
Abstract:
Not Available Laser weapon systems currently under development, such as the Airborne Laser (ABL), must successfully fire laser beams over long horizontal paths through the atmosphere. Pointing the laser to hit the target in this scenario requires compensation for at least three effects: 1) target… More

METHOD FOR STERILIZATION OF HUMAN PLASMA AND PLATELETS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,700.00
Agency:
HHS
Principal Investigator:
Robert E. Raulli
Abstract:
N/a

A method for sterilization of human plasma and platelets

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Robert E. Raulli
Abstract:
DESCRIPTION (provided by applicant): This proposal is to develop a method to prolong the shelf-life and increase the safety of human platelets with a unique method of sterilization. The method delivers an agent known to kill a range of microbial pathogens in vitro including many… More

A method for sterilization of human plasma and platelets

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$472,075.00
Agency:
HHS
Principal Investigator:
Robert E. Raulli
Abstract:
DESCRIPTION (provided by applicant): This proposal is to develop a method to prolong the shelf-life and increase the safety of human platelets with a unique method of sterilization. The method delivers an agent known to kill a range of microbial pathogens in vitro including many… More

Biofilm development and Eye Infections

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$117,240.00
Agency:
HHS
Principal Investigator:
Abstract:
Contact lens related eye infections impact millions of people yearly. Standard guidelines for lens care can minimize eye infection, but it has been shown that only about 50% of lens wearers adhere to appropriate guidelines. During usual use and storage procedures, microorganisms adhere to contact… More

Treatment of diabetic gastroparesis with nitric oxide

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$367,554.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This proposal will establish proof of concept for the use of nitric oxide (NO) as an effective treatment for diabetic gastroparesis. The NO will be delivered using Amulet's NORTECH nitric oxide releasing technology. NOR TECH delivers NO in a predictable and… More